DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Fairchem Organics Limited — Board Meeting Intimation

NSE 1 hr ago·10 Oct 2026, 4:55 am

Fairchem Organics

Fairchem Organics Ltd has announced a board meeting on 22 Oct 2026 to review and approve its unaudited financial results for the quarter ended September 2026, together with any other routine business.

The meeting is a standard regulatory step, but the unaudited numbers give investors an early view of revenue, profit margins and cash‑flow trends before the audited statements are filed. Any material surprise—positive or negative—can influence the share price, so market participants typically monitor these releases closely.

Investors should watch for the company’s earnings press release after the meeting, any management commentary, and the subsequent formal filing with the exchange. Analyst notes and market reaction will help gauge the impact on Fairchem’s outlook.